An Exploration of the Safety of “Pneumonia Prevention No. 1” in Healthy Populations

References

• Andersen G, Andrew Rambaut W, Lipkin I, et al. The proximal origin of SARS-CoV-2. Nat Med. 2020;26(4):450–452. doi:10.1038/s41591-020-0820-9
   PubMed Web of Science ®Google Scholar
• Forster P, Forster L, Renfrew C, Forster M. Phylogenetic network analysis of SARS-CoV-2 genomes. Proc Natl Acad Sci USA. 2020;117(17):9241–9243. doi:10.1073/pnas.2004999117
   PubMed Web of Science ®Google Scholar
• Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern. Lancet. 2020;395(10223):470–473. doi:10.1016/S0140-6736(20)30185-9
   PubMed Web of Science ®Google Scholar
• Zhu N, Zhang D, Wang W, et al. China novel coronavirus investigating and research team. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727–733. doi:10.1056/NEJMoa2001017
   PubMed Web of Science ®Google Scholar
• Chen Y, Liu Q, Guo D. Emerging coronaviruses: genome structure, replication, and pathogenesis. J Med Virol. 2020;92(4):418–423. doi:10.1002/jmv.25681
   PubMed Web of Science ®Google Scholar
• Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020;382(13):1199–1207. doi:10.1056/NEJMoa2001316
   PubMed Web of Science ®Google Scholar
• Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. doi:10.1016/S0140-6736(20)30183-5
   PubMed Web of Science ®Google Scholar
• Wang Z, Yang B, Li Q, Wen L, Zhang R. Clinical features of 69 cases with coronavirus disease 2019 in Wuhan, China. Clin Infect Dis. 2020;71(15):769–777. doi:10.1093/cid/ciaa272
   PubMed Web of Science ®Google Scholar
• Guan W-J, Zheng-yi N, Yu H, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382:1708–1720. doi:10.1056/NEJMoa2002032
   PubMed Web of Science ®Google Scholar
• The Xinhua News Agency. WHO director-general’s statement on IHR emergency committee on novel coronavirus; 2020.
   Google Scholar
• World Health Organization. Address by the Director-General of WHO at the Media Briefing on the 2019 New Coronavirus. Geneva: World Health Organization; 2020.
   Google Scholar
• World Health Organization, WHO Director-General’s opening remarks at the media briefing on COVID-19; 2020.
   Google Scholar
• Yang Y, Lu Q, Liu M, et al. Epidemiological and clinical features of the 2019 novel coronavirus outbreak in China. medRxiv. 2020;2020:1.
   Google Scholar
• Sanche S, Lin YT, Xu C, Romero-Severson E, Hengartner N, Ke R. High contagiousness and rapid spread of severe acute respiratory syndrome coronavirus 2. Emerg Infect Dis. 2020;26(7):1470–1477. doi:10.3201/eid2607.200282
   PubMed Web of Science ®Google Scholar
• Yifan C. The largest number of cases so far, the new coronary pneumonia study shows that the previous basic infection number of 2.2 may be underestimated. Economic Observer Network; 2020.
   Google Scholar
• Chen N, Min Z, Xuan D, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507–513. doi:10.1016/S0140-6736(20)30211-7
   PubMed Web of Science ®Google Scholar
• Diao B, Wang C, Tan Y, et al. Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19). Front Immunol. 2020;11:827. doi:10.3389/fimmu.2020.00827
   PubMed Web of Science ®Google Scholar
• Godeau D, Petit A, Richard I, Roquelaure Y, Descatha A. Return-to-work, disabilities and occupational health in the age of COVID-19. Scand J Work Environ Health. 2021;47(5):408–409. doi:10.5271/sjweh.3960
   PubMed Web of Science ®Google Scholar
• Lin L, Xia Z, Yuejun L, et al. Effect of Hunan prevention new coronary pneumonia No.1 prescription on human cellular immunity and humoral immunity. Guid J Trad Chin Med Pharm. 2020;26(10):8–11.
   Google Scholar
• Congmin Z, Jinkai W, Xiaojing Z, et al. Research progress on immunopharmacological effects of Yupingfeng granules. Modern J Integr Tradit West Med. 2020;29(20):2274–2277.
   Google Scholar
• Sheng Y, Zhonglin Z, Mingyong Y, Lingli Z. Effect of Yupingfeng powder on the immune function of rats with lung-qi deficiency syndrome. J China Pharm. 2016;27(22):3041–3044.
   Google Scholar
• Lina G, Zheng X. Research progress of clinical application and pharmacology of Yupingfeng powder. Shandong J Tradit Chin Med. 2020;39(12):1369–1374.
   Google Scholar
• Declaration of Helsinki. Ethical principles for medical research involving human subjects. Jahrbuch für Wissenschaft und ethik; 2014.
   Google Scholar
• ICH. E6(R2) Guideline for good clinical practice; 2019.
   Google Scholar
• State Food and Drug Administration, National Health Commission. ”Good clinical practice for drugs”; 2020.
   Google Scholar
• Food and Drug Administration. Guidelines for general considerations in drug clinical trials [EB/OL]; 2017.
   Google Scholar
• Xuan-Xuan XU, Ling-Ru LI, Yan-Ling WU, et al. Study on dual immunoregulatory mechanism of yupingfeng powder from aspects of external asthenia and latent pathogens. J Anhui Univ Chin Med. 2015;34(2):1–3.
   Google Scholar
• Fahao C. Preparation of Compound Ginsenoside Nanoemulsion and Its Immune Enhancement Effect. Xianyang: Northwest Sci-Tech University of Agriculture and Forestry; 2012. Chinese.
   Google Scholar
• Lili H, Puyang G, Yue F, Wei Z, Enlong W, Jian G. Analysis on application of Chinese materia medica in treatment of COVID-19 by suppressing cytokine storm. China Tradit Herb Drugs. 2020;51(6):1.
   Google Scholar
• Stearns-Kurosawa DJ, Osuchowski MF, Valentine C, et al. The pathogenesis of sepsis. Annu Rev Pathol. 2011;6:19–48. doi:10.1146/annurev-pathol-011110-130327
   PubMed Web of Science ®Google Scholar
• Wang W, Chen J, Yu X, Lan HY. Signaling mechanisms of SARS-CoV-2 Nucleocapsid protein in viral infection, cell death and inflammation. Int J Biol Sci. 2022;18(12):4704–4713. doi:10.7150/ijbs.72663
   PubMed Web of Science ®Google Scholar
• Yang L, Xie X, Tu Z, Fu J, Xu D, Zhou Y. The signal pathways and treatment of cytokine storm in COVID-19. Signal Transduct Target Ther. 2021;6(1). doi:10.1038/s41392-021-00679-0
   Web of Science ®Google Scholar
• Quinton LJ, Mizgerd JP. Dynamics of lung defense in pneumonia: resistance, resilience, and remodeling. Annu Rev Pathol. 2015;77:407–430.
   Google Scholar
• Jiao L, Min F. Severe pulmonary infections and immune disorders: problems and prospects. Chin J Pract Intern Med. 2022;42(03):196–201.
   Google Scholar
• Ruiqing G, Xiangben M. Pharmacological and clinical research progress of Yupingfeng powder in respiratory diseases. Zhejiang J Tradit Chin Med. 2003;2003(7):44–45.
   Google Scholar
• Min H, Liang W, Jie Z, et al. The characteristics of different extracts of Yupingfeng powder in inhibiting delayed-type hypersensitivity reactions. Chin Med Pharmaco Clinic. 2010;26(2):4.
   Google Scholar
• Qinghe P, Shengrong C, Shu Z, et al. Effect of jade screen powder combined with six gentlemen decoction of. J Liaoning Univ Tradit Chin Med. 2013;15(10):95.
   Google Scholar
• Fangjun C. Protective Effects of Total Polysaccharides Fromyu-Ping-Feng Powder on Acute Liver Injury and Study on Its Mechanism. Hefei: Anhui Medical University; 2008.
   Google Scholar
• Liu LT, Li J, Peng GY, et al. Analysis of similarities and differences between coronavirus disease 2019 and severe acute respiratory syndrome. World J Tradit Chin Med. 2020;6:145–151. doi:10.4103/wjtcm.wjtcm_21_20
   Google Scholar
• Jia L, Baofei Y, Mingyue Z, et al. Potential mechanism of couplet medicines baical skullcap root-honeysuckle for coronavirus disease 2019 based on network pharmacology. WJTCM. 2020;15(4):502–511.
   Google Scholar
• Yuexi C, Hegang L. The advance of the research on cyrtomium fortunei. Mod Chin Med. 2014;16(12):1043–1048. Chinese.
   Google Scholar
• Zhihao X, Jian Q, Xiaobing P, et al. Favorable outcome of adjunctive traditional Chinese medicine therapy in liver cirrhosis: a large cohort study in Southwest China. Complement Ther Med. 2020;51:1–8.
   Web of Science ®Google Scholar
• Changya W. Discussion on the pharmacological effects of dried tangerine peel. Electronic J Clin Med Lit. 2020;7(15):135.
   Google Scholar
• Wenli W, Qiuling W. Application and research progress of eupatorium fortunei. Strait Pharm J. 2019;31(6):28–30. Chinese.
   Google Scholar